Scholars Central

Research articlePublished 2012

Post-Transplant Hypomagnesemia in Turkish Renal Transplant Recipients: The Frequency and Related Factors

Authors: Aydin Unal, Ismail Kocyigit, Feridun Kavuncuoglu, Murat Hayri Sipahioglu, Bulent Tokgoz, Oktay Oymak, Cengiz Utas

Journal of Nephrology & Therapeutics

Volume 2 · Issue 6 · Pages 1–5

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Aim: Hypomagnesemia is a frequent complication in RTRs, particularly in the early post-transplant period. Hypomagnesemia is usually associated with the use of calcineurin inhibitors. The relationship between cyclosporine use and hypomagnesemia is well known. However, it has been reported in several studies that hypomagnesemia was seen more in RTRs treated with tacrolimus compared to those treated with cyclosporine. In this study, we aimed to investigate the frequency and risk factors of post-transplant hypomagnesemia and effects of calcineurin inhibitors on hypomagnesemia among Turkish patients. Patients and method: The study included 68 adult renal transplantation recipients. Hypomagnesemia was defined as serum magnesium level <1.4 mEq/L. Result: Hypomagnesemia were found in 26 (38.2%) of the 68 patients. Levels of serum calcium and glucose were significantly higher in hypomagnesemic group compared to normomagnesemic group (9.7 ± 0.5 mg/dL vs. 8.4 ± 0.5, p: 0.029 and 107.3 ± 19.1 mg/dL vs. 95.8 ± 16.1, p: 0.010, respectively). Post-transplant duration was meaningfully longer in normomagnesemic group (9.5 months vs. 46.5, p: 0.001). Serum magnesium level was meaningfully higher in patients with cyclosporine compared to patients treated with tacrolimus (1.44 ± 0.5 mEq/L vs. 1.52 ± 0.2, p: 0.002, respectively). Post-transplant duration was significantly longer in cyclosporine group (12 months vs. 98.5, p: 0.001). Frequency of hypomagnesemia was significantly higher tacrolimus group (58% vs. 10%, p: 0.001). Conclusion: The frequency of hypomagnesemia was high among Turkish renal transplant recipients, especially those treated with tacrolimus. Increased concentrations of serum calcium and glucose and the shorter post-transplant duration were risk factors for post-transplant hypomagnesemia.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Nephrology & Therapeutics.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Nephrology & Therapeutics
  • SubjectNephrology & Urology
  • BylineArticles whose byline prints “Aydin Unal”
  • BylineArticles whose byline prints “Ismail Kocyigit”
  • BylineArticles whose byline prints “Feridun Kavuncuoglu”
  • BylineArticles whose byline prints “Murat Hayri Sipahioglu”
  • BylineArticles whose byline prints “Bulent Tokgoz”
  • BylineArticles whose byline prints “Oktay Oymak”
  • BylineArticles whose byline prints “Cengiz Utas”